Generate a tailored SOP for Dr. Lili Yang. Improve your application with a focused, well-structured draft.
Lili Yang is a Professor in the Department of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles (UCLA). Her research focuses on understanding how the immune system responds to diseases, particularly cancer and HIV/AIDS. Dr. Yang's work aims to develop effective therapies that engineer the immune system to combat these ailments by manipulating patients' blood cells. Yang has shown that hematopoietic stem cells and various immune cells can be engineered to promote immune responses against diseases. She is part of a collaborative research group, the Translational Consortium for Engineered Immunity, which involves multiple disciplines and institutions, including UCLA, the California Institute of Technology (Caltech), and the University of Southern California. Throughout her career, Dr. Yang has published several notable articles that explore the intricate dynamics of T-cell responses and the engineering of immune cells to provide better therapeutic options. Her current research aims to translate laboratory discoveries into clinical applications, thereby improving treatment strategies for patients suffering from cancer.
University of California, Los Angeles • Los Angeles, CA
Teaching and conducting research in the field of immunology.
Department of Economics admits primarily for the PhD program.